UNSPSC 51283408: Prazocillin

This classification denotes a penicillin antibiotic with the molecular formula C19H18Cl2N4O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier IRZ1462XXF, chemically known as 6-(1-(2,6-dichlorophenyl)-4-methylpyrazole-5-carboxamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as prazocillin, which bears US NIH Compound Identifier 65622. European Medicines Agency schedules Prazocillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10010MIG.

UNSPSC 51283408 Prazocillin is a Commodity code under which state and local governments procure pharmaceutical products, though the recent solicitation activity under this code shows minimal relevance to prazocillin specifically. The opportunities recorded instead cover naloxone, generic multi-source pharmaceuticals, over-the-counter products, and direct-to-manufacturer prescription programs—a mismatch suggesting that either the code assignment is erroneous or prazocillin procurement is not currently active in tracked state and local markets. Issuing bodies soliciting pharmaceutical and pharmaceutical-adjacent products include county health departments (Seminole County, Florida), state health and human services commissions (Texas HHS), municipal fire and rescue divisions (City of Tampa), and multi-state cooperative purchasing consortia (Minnesota Multistate Cooperative Purchasing Alliance / MMCAP). The mix reflects demand across public health, emergency medical services, and broader state-local pharmacy benefit administration.

Geographic activity centers on Florida, Texas, and Minnesota, with MMCAP's multi-state membership extending to Oregon. Representative recent opportunities include Seminole County's IFB for naloxone and drug deactivation systems (due July 26, 2023, with quarterly delivery to a county health facility), the City of Tampa's invitation to bid for medical and first aid supplies for its fire department rescue division (estimated at $700,000, with a 5% certified Small Local Business Enterprise bid discount available, due March 13, 2026), MMCAP's RFP for generic multi-source pharmaceuticals and OTC products (responses due March 26, 2026, with July 1, 2026 contract effective date), and the Texas HHS Commission's Request for Information on direct-to-manufacturer prescription programs (response deadline April 3, 2026). The code shows little demonstrable prazocillin procurement activity; state and local buyers in this space are actively sourcing naloxone, emergency medical supplies, and generic pharmaceutical products through established wholesaler networks and cooperative purchasing vehicles.